4.5 Article

Treatment of Femoral Head Osteonecrosis with Ozone Therapy: Pilot Trial of a New Therapeutic Approach

期刊

PAIN PHYSICIAN
卷 25, 期 1, 页码 E43-E54

出版社

AM SOC INTERVENTIONAL PAIN PHYSICIANS

关键词

Osteonecrosis of the femoral head; ozone therapy; hip injection; pain intensity; hip function; differential expressed genes; gene ontology; transcriptomics

向作者/读者索取更多资源

Ozone therapy showed significant pain relief, improvement in hip function, and resolution of bone marrow edema in the treatment of osteonecrosis of the femoral head. There was a lower rate of conversion to total hip arthroplasty in the ozone therapy group compared to the control group.
Background: Osteonecrosis of the femoral head (ONFH) is a progressive and painful disorder due to impaired blood supply to the femoral head, yet little is known about the effect of ozone therapy in femoral head necrosis. Objectives: We aimed to evaluate the clinical and radiographic outcomes of ozone therapy in the treatment of ONFH. Study Design: Nonrandomized clinical trial. Settings: The study was conducted in a single-center, academic institution. Methods: A total of 71 patients (107 hip joints) with Association Research Circulation Osseous (ARCO) stage-I, II, III, and IV ONFH were included and assigned to undergo either intraarticular O-2-O-3 mixture hip injections with ozonated autohemotherapy (ozone therapy group, n = 39, 58 hip joints) or protected weight bearing (control group, n = 32, 49 hip joints). The primary outcomes included the Visual Analog Scale (VAS) for pain intensity and Harris Hip Score (HHS) for hip function. The secondary outcomes included bone marrow edema examination, and conversion to total hip arthroplasty (THA). Results: Ozone therapy effectively improves VAS for pain intensity and HHS during the follow-up period compared to the control group. Ozone therapy showed a significant resolution of bone marrow edema of the femoral head compared to the control group (P < 0.001). Thirteen of the 49 hips (26.53%) in the control group underwent THA, whereas only 6 hips (10.34%) in the ozone therapy group required THA during a 30-month follow-up (P = 0.041). The cumulative analysis revealed a low rate of conversion to THA in the ozone therapy group (logrank test; P = 0.022). Limitations: The study is limited by a single treatment protocol in addition to the lack of a randomized design. Conclusions: Ozone therapy was associated with significant pain relief, improvement in hip function, and bone marrow edema resolution that may delay the need for THA in patients affected by ONFH.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据